Ojocef-S 1.5 Injection
Marketer
Ojana Pharmaceutical Pvt Ltd
Salt Composition
Ceftriaxone (1000mg) + Sulbactam (500mg)
Overview Ojocef-S 1.5 Injection
Cefixime and Sulbactam injection (Ojocef-S 1.5) is a dual-action antibiotic indicated for a range of bacterial infections. Its mechanism combats microbial proliferation, halting infection progression. Administration must be strictly under medical guidance. Consistent adherence to the prescribed schedule is crucial; complete the full course regardless of symptom improvement. Premature cessation can compromise treatment efficacy. Commonly reported side effects include nausea, vomiting, diarrhea, and dyspepsia. Escalating side effects require immediate medical attention. Seek urgent medical care for allergic reactions (skin rashes, itching, edema, respiratory distress). Inform your physician of all current medications, including those for pre-existing conditions, before commencing treatment. Pregnant or lactating individuals should consult their doctor prior to use. Alcohol consumption should be avoided due to potential increased drowsiness. While generally non-impairing to driving ability, avoid operating vehicles if experiencing somnolence or dizziness. Adequate rest, nutrition, and hydration are essential for optimal recovery. Your physician may order blood tests and other assessments to monitor treatment response.
Primary Ingredients of Ojocef-S 1.5 Injection
No text was provided to rephrase. Please provide the text you wish to be rewritten.
Uses of Ojocef-S 1.5 Injection
Infections caused by bacteria
Major Benefits of Ojocef-S 1.5 Injection:
Administering this medication will be done by your physician or their qualified staff; self-medication is strictly prohibited.
Common Side effects of Ojocef-S 1.5 Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Ojocef-S 1.5 Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Ojocef-S 1.5 Injection works:
Ojocef-S 1.5 Injection combines the antibiotic Ceftriaxone with the beta-lactamase inhibitor Sulbactam. Ceftriaxone's mechanism involves disrupting bacterial cell wall synthesis, a crucial process for bacterial viability. Sulbactam counters bacterial resistance mechanisms, thereby boosting Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
Ingestion of alcohol alongside Ojocef-S 1.5 Injection presents no known adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable medication Ojocef-S 1.5 is generally deemed safe for use in pregnancy. Preclinical trials in animals revealed minimal or no harmful effects on fetal development; nonetheless, clinical data from human trials remain scarce.
Breast feedingCAUTION
Administering Ojocef-S 1.5 Injection to breastfeeding mothers requires careful consideration. Discontinue breastfeeding throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingUNSAFE
Administering Ojocef-S 1.5 Injection might induce drowsiness, blurred vision, or dizziness. Driving should be avoided if these side effects manifest.
KidneyCONSULT YOUR DOCTOR
Data regarding Ojocef-S 1.5 Injection use in individuals with renal impairment is scarce. Physician consultation is advised.
LiverCAUTION
Patients with severe hepatic impairment should use Ojocef-S 1.5 Injection cautiously, potentially requiring dosage modification. Consult a physician for guidance. Dosage alteration for Ojocef-S 1.5 Injection isn't advised for individuals with mild or moderate liver dysfunction.
What if you forget to take Ojocef-S 1.5 Injection :
Omit doses of Ojocef-S 1.5 Injection only after discussing this with your physician.
Facts to Know About Ojocef-S 1.5 Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Antimicrobials |
3,018 People bought this recently